Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00735670 · ClinicalTrials.gov registry record · NA

Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury

A NA study of Spinal Cord Injury, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT00735670: Completed NA study of Spinal Cord Injury, sponsored by University of Michigan.

NCT00735670 is a NA study of Spinal Cord Injury that has completed, run by University of Michigan. The registered enrollment target is 34 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00735670, a NA study of Spinal Cord Injury, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This study was initially designed to test the efficacy of Venlafaxine HCl in reducing incidence of the onset of major depression after a new spinal cord injury (SCI). After several protocol modifications, the purpose of the study is to test the effectiveness of a sub-therapeutic dose of Venlafaxine HCl to reduce mild to moderate symptoms in persons with SCI.

Primary Outcome

The QIDS assesses symptoms of depression across the nine DSM-IV criterion domains for major depressive episode. The primary end-point in this study was the number of participants who had a \>50% change in scores on the QIDs from baseline to week 13 (end of treatment period).

Conditions Studied

Spinal Cord Injury

Interventions

  • OTHER Placebo
  • DRUG Venlafaxine HCl

Study Locations (1)

Michigan

  • University of Michigan Model SCI Care System - Ann Arbor

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2008-06
Est. Completion 2012-08
Phase NA
University of Michigan

1,327 total trials

What the finished NCT00735670 record still lists

NCT00735670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00735670 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT00735670 about?

NCT00735670 is a clinical study titled "Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury". This study was initially designed to test the efficacy of Venlafaxine HCl in reducing incidence of the onset of major depression after a new spinal cord injury (SCI). After several protocol modifications, the purpose of the study is to test the effectiveness of a sub-therapeutic dose of Venlafaxine ...

What is the current status of trial NCT00735670?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2008-06. Estimated completion is 2012-08.

What conditions does trial NCT00735670 study?

This clinical trial studies the following conditions: Spinal Cord Injury.

What interventions are being tested in trial NCT00735670?

The interventions under investigation include: Placebo (OTHER), Venlafaxine HCl (DRUG).

Who is sponsoring clinical trial NCT00735670?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00735670 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00735670's enrollment target sits among peer trials

34 43rd of 99 higher than 56 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00735670, the US trial registry maintained by the National Library of Medicine. NCT00735670 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.